相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer
Elif Asik et al.
NANOMEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer
Haci Ahmet Bircan et al.
LUNG CANCER (2018)
Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer
Cheolwon Choi et al.
ONCOTARGET (2016)
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
Zuhal Hamurcu et al.
ONCOTARGET (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer
L. L. Fu et al.
APOPTOSIS (2014)
Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells
Chuan-Ming Xie et al.
AUTOPHAGY (2014)
Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion
Ahmed A. Ashour et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells
Yan Cheng et al.
AUTOPHAGY (2013)
The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
Gabriel Leprivier et al.
CELL (2013)
Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes
Marco Beausejour et al.
APOPTOSIS (2012)
Investigating the Kinetic Mechanism of Inhibition of Elongation Factor 2 Kinase by NH125: Evidence of a Common in Vitro Artifact
Ashwini K. Devkota et al.
BIOCHEMISTRY (2012)
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
Ibrahim Tekedereli et al.
PLOS ONE (2012)
Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression
Yi Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
eEF-2 Kinase Dictates Cross-Talk between Autophagy and Apoptosis Induced by Akt Inhibition, Thereby Modulating Cytotoxicity of Novel Akt Inhibitor MK-2206
Yan Cheng et al.
CANCER RESEARCH (2011)
Cyclin D1 predicts the prognosis of advanced serous ovarian cancer
Tomoko Hashimoto et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nanomedicine based approaches for the delivery of siRNA in cancer
B. Ozpolat et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Nagathihalli S. Nagaraj et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Cytoprotective Effect of the Elongation Factor-2 Kinase-Mediated Autophagy in Breast Cancer Cells Subjected to Growth Factor Inhibition
Yan Cheng et al.
PLOS ONE (2010)
Silencing of Elongation Factor-2 Kinase Potentiates the Effect of 2-Deoxy-D-Glucose against Human Glioma Cells through Blunting of Autophagy
Hao Wu et al.
CANCER RESEARCH (2009)
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
Ursula A. Matulonis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells
Ugur Akar et al.
AUTOPHAGY (2008)
Cancer antigen 125 and prognosis
Estrid Hogdall
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2008)
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study
Robert A. Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
Stephen A. Cannistra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
PKCδ and tissue transglutarninase in pancreatic cancer cells are novel inhibitors of autophagy
Bulent Ozpolat et al.
AUTOPHAGY (2007)
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy
Jyotsnabaran Halder et al.
CLINICAL CANCER RESEARCH (2006)
Elongation factor-2 kinase regulates autophagy in human glioblastoma cells
H Wu et al.
CANCER RESEARCH (2006)
New tumor markers: CA125 and beyond
RC Bast et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
Symptoms associated with diagnosis of ovarian cancer: a systematic review
CR Bankhead et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
Unlocking the potential of the human genome with RNA interference
GJ Hannon et al.
NATURE (2004)
Inhibition of Src tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice
MV Yezhelyev et al.
CLINICAL CANCER RESEARCH (2004)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Expression level of integrin α5 on tumour cells affects the rate of metastasis to the kidney
N Tani et al.
BRITISH JOURNAL OF CANCER (2003)
Src family kinases in tumor progression and metastasis
JM Summy et al.
CANCER AND METASTASIS REVIEWS (2003)
New insights into the role of nuclear factor-κB in cell growth regulation
F Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
